• All
  • Article Title
  • Abstract
  • Keywords
  • Author
  • Institution
  • Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Targeting HER2 in breast cancer: new drugs and paradigms on the horizon”.
    No. Publication Date Citing Article
    1 2022 Rossella Loria, Patrizia Vici, Francesca Sofia Di Lisa, Silvia Soddu, Marcello Maugeri-Saccà, Giulia Bon. Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue, Frontiers in Oncology. 2022; 12: 877380.  https://doi.org/10.3389/fonc.2022.877380
    2 2024 Parastoo Shahrouzi, Youness Azimzade, Wioletta Brankiewicz, Sugandha Bhatia, David Kunke, Derek Richard, Xavier Tekpli, Vessela N. Kristensen, Pascal H.G. Duijf. 2024;   https://doi.org/10.21203/rs.3.rs-4594599/v1
    3 2024 Soo-Yeon Hwang, Kyung-Hwa Jeon, Hwa-Jong Lee, Inhye Moon, Sehyun Jung, Seul-Ah Kim, Hyunji Jo, Seojeong Park, Misun Ahn, Soo-Yeon Kwak, Younghwa Na, Youngjoo Kwon. 2024;   https://doi.org/10.7554/eLife.97051.1
    4 2024 Parastoo Shahrouzi, Youness Azimzade, Wioletta Brankiewicz, Sugandha Bhatia, David Kunke, Derek Richard, Xavier Tekpli, Vessela N. Kristensen, Pascal H.G. Duijf. 2024;   https://doi.org/10.1101/2024.06.18.599481
    5 2024 Soo-Yeon Hwang, Kyung-Hwa Jeon, Hwa-Jong Lee, Inhye Moon, Sehyun Jung, Seul-Ah Kim, Hyunji Jo, Seojeong Park, Misun Ahn, Soo-Yeon Kwak, Younghwa Na, Youngjoo Kwon. 2024;   https://doi.org/10.1101/2024.03.01.583029
    6 2025 Warisha Kanwal, Kaneez Narjis, Sarah Musani, Fnu Nancy, Laiba Qureshi, Muhammad Mudasir, Rohma Naseem, Fnu Tooba, Juvairia Yousuf, Kanza Farhan, Hadiya Javed, Mohammed Mahmmoud Fadelallah Eljack. Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review, BMC Cancer. 2025; 25: 382.  https://doi.org/10.1186/s12885-025-13749-1
    7 2024 Soo-Yeon Hwang, Kyung-Hwa Jeon, Hwa-Jong Lee, Inhye Moon, Sehyun Jung, Seul-Ah Kim, Hyunji Jo, Seojeong Park, Misun Ahn, Soo-Yeon Kwak, Younghwa Na, Youngjoo Kwon. 2024;   https://doi.org/10.7554/eLife.97051.2
    8 2024 Luying Xu, Yuxin Xie, Qiheng Gou, Rui Cai, Rong Bao, Yucheng Huang, Ruisi Tang. HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future, Frontiers in Pharmacology. 2024; 15: 1446414.  https://doi.org/10.3389/fphar.2024.1446414
    9 2024 Soo-Yeon Hwang, Kyung-Hwa Jeon, Hwa-Jong Lee, Inhye Moon, Sehyun Jung, Seul-Ah Kim, Hyunji Jo, Seojeong Park, Misun Ahn, Soo-Yeon Kwak, Younghwa Na, Youngjoo Kwon. Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction, eLife. 2024; 13: RP97051.  https://doi.org/10.7554/eLife.97051
    10 2024 Soo-Yeon Hwang, Kyung-Hwa Jeon, Hwa-Jong Lee, Inhye Moon, Sehyun Jung, Seul-Ah Kim, Hyunji Jo, Seojeong Park, Misun Ahn, Soo-Yeon Kwak, Younghwa Na, Youngjoo Kwon. Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction, eLife. 2024; 13: RP97051.  https://doi.org/10.7554/eLife.97051.3